Cargando…

Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism

BACKGROUND: Angiopoietin-like protein 8(ANGPTL8) and apolipoprotein CIII (apoCIII) were found to inhibit the activity of lipoprotein lipase (LPL) and disrupt the clearance of triglyceride-rich lipoproteins (TRLs), leading to hypertriglyceridemia. Whether any relationship exists between these two imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Mengdie, Su, Xin, Yi, Yuhong, Yang, Yang, Peng, Daoquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052593/ https://www.ncbi.nlm.nih.gov/pubmed/30021607 http://dx.doi.org/10.1186/s12944-018-0777-6

Ejemplares similares

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism
por: Luo, Mengdie, et al.
Publicado: (2016)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017)

Angiopoietin-Like Protein 4 May Be an Interplay Between Serum Uric Acid and Triglyceride-Rich Lipoprotein Cholesterol
por: Peng, Yani, et al.
Publicado: (2022)

Volanesorsen, an Antisense Oligonucleotide to Apolipoprotein-CIII, Decreases Triglycerides and Increases Lipoprotein Lipase Activity in Partial Lipodystrophy
por: Lightbourne, Marissa, et al.
Publicado: (2021)

Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome
por: van der Ham, Rachel L.M., et al.
Publicado: (2009)

Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
por: Guan, Yunpeng, et al.
Publicado: (2021)

Meal-Related Changes in Apolipoprotein Particles After Treatment With an Antisense Oligonucleotide to Apolipoprotein CIII
por: Brite, Brianna, et al.
Publicado: (2021)

Lowering apolipoprotein CIII protects against high-fat diet–induced metabolic derangements
por: Valladolid-Acebes, Ismael, et al.
Publicado: (2021)

ANGPTL8: An Important Regulator in Metabolic Disorders
por: Luo, Mengdie, et al.
Publicado: (2018)

Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes
por: HU, ZHI-JUAN, et al.
Publicado: (2014)

Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men
por: Faghihnia, Nastaran, et al.
Publicado: (2012)

Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle
por: Valladolid-Acebes, Ismael, et al.
Publicado: (2021)

CD14(+)-Monocytes Exposed to Apolipoprotein CIII Express Tissue Factor
por: Olivieri, Oliviero, et al.
Publicado: (2023)

Relationship Between Angiopoietin-Like Protein 8 and Fasting Serum Triglyceride Level
por: Yamada, Hodaka, et al.
Publicado: (2018)

Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells
por: Sol, E-ri M, et al.
Publicado: (2009)

Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry
por: Demus, Daniel, et al.
Publicado: (2021)

The relationship between apolipoprotein CIII gene polymorphism and serum lipid levels in Han Chinese males()
por: Su, Shu, et al.
Publicado: (2013)

Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion
por: Zheng, Chunyu, et al.
Publicado: (2013)

Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids
por: Naber, Annemieke, et al.
Publicado: (2023)

APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome
por: Fallaize, Rosalind, et al.
Publicado: (2017)

Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans
por: Hieronimus, Bettina, et al.
Publicado: (2019)

Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
por: Lee, Hui-Young, et al.
Publicado: (2011)

Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
por: Taskinen, Marja-Riitta, et al.
Publicado: (2016)

Mass Spectrometry of Transferrin and Apolipoprotein CIII from Dried Blood Spots for Congenital Disorders of Glycosylation
por: Wada, Yoshinao, et al.
Publicado: (2022)

Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes
por: Christopoulou, Eliza, et al.
Publicado: (2019)

Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
por: Sylvers-Davie, Kelli L., et al.
Publicado: (2021)

SstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province
por: Bandegi, Ahmad Reza, et al.
Publicado: (2011)

Association of serum lipids and coronary artery disease with polymorphisms in the apolipoprotein AI-CIII-AIV gene cluster
por: Rai, Himanshu, et al.
Publicado: (2016)

Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
por: Katzmann, Julius L., et al.
Publicado: (2020)

The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2018)

Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death
por: Paiva, Adriene A., et al.
Publicado: (2017)

A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening
por: Lee, Sang Jun, et al.
Publicado: (2017)

Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice
por: Recio-López, Patricia, et al.
Publicado: (2021)

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
por: Ahmad, Zahid, et al.
Publicado: (2019)

Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China
por: Zheng, Tianpeng, et al.
Publicado: (2018)

Apolipoprotein CIII regulates lipoprotein-associated phospholipase A(2) expression via the MAPK and NFκB pathways
por: Han, Xiaolei, et al.
Publicado: (2015)

Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele
por: Olivieri, Oliviero, et al.
Publicado: (2013)

Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII
por: Olivieri, Oliviero, et al.
Publicado: (2019)

Electrospray Ionization Mass Spectrometry of Apolipoprotein CIII to Evaluate O-glycan Site Occupancy and Sialylation in Congenital Disorders of Glycosylation
por: Wada, Yoshinao, et al.
Publicado: (2022)

Apolipoprotein A5 regulates intracellular triglyceride metabolism in adipocytes
por: Zheng, Xiao-Yan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lmhrk1af7ob9ekoldvo72h9pq2